Skip to main content

Interleukin Collaborates with Geisinger Health on Obesity Genetics

NEW YORK (GenomeWeb News) — Interleukin Genetics will collaborate with Pennsylvania-based Geisinger Health System to study the role of certain genes in obesity, the company said today.
The aim of the project is to develop genetic tests that will indicate a patient's inherited
resistance to weight loss "and, more specifically, gauge a patient's likelihood of success with diet and other weight loss techniques," the company said. 

Interleukin Genetics said it will use Geisinger’s health records and medical knowledge of obesity to develop the tests.

Geisinger and Interleukin Genetics will conduct a case control retrospective study to analyze variations of perilipin, interleukin 1, and “a select number of other genes,” the company said.
Geisinger is comprised of three medical centers, a Center for Health Research, and a non-profit health insurance company.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.